<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7WMMLK" height="0" width="0" style="display:none;visibility:hidden"></iframe>

GC Aesthetics® 您的終身伴侶

提供高品質的產品,讓患者在乳房增強過程中感到自信和安全。

總部設在英國

1979

成立於法國

1988

收購Eurosilicone & Nagor

2008

推出第六代凝膠

2015

朝著解決方案提供者的方向發展

2017

實施創新路徑策略

2018

推出 NOA™,Eve 4.0™ ,並發表 十年臨牀研究

2019

推出 PERLE™,HydroCone™ 和 GCA Comfort Plus™ 保固

2020

Eurosilicone™ 和 Nagor™ 品牌正全面轉型為 GCA®

2021

推出 FixNip™ NRI

2022

推出 Luna XT™

2023

推出 Puregraft® 和 Healena™

2024

GCA® 的不同

More than 3 million breast implants placed in the last 10 years, supported by published 10-year clinical data demonstrating compelling safety and effectiveness in aesthetic and reconstructive breast surgery.
Our round and anatomical silicone gel breast implants are backed by long-term peer-reviewed studies evaluating safety, patient satisfaction, and revision rates.
Published clinical evidence includes:

  • Ten-Year Safety Data for Eurosilicone’s Round and Anatomical Silicone Gel Breast Implants (Aesthetic Surgery Journal Open Forum, 2019)
  • Single-Center and Surgeon’s Long-Term (15–19 Years) Patient Satisfaction and Revision Rate of Round Textured Eurosilicone Breast Implants (Aesthetic Surgery Journal, 2021)

This long-term follow-up reinforces our commitment to reliable breast implant performance and evidence-based medical device development.

To design, develop, manufacture, market, and offer best-in-class medical aesthetic solutions that contribute to women’s healthcare, well-being, confidence, empowerment, and overall happiness through safe, reliable breast implant devices placed in the hands of trained and qualified surgeons.

We are committed to advancing standards in breast augmentation and breast reconstruction by combining:

  • Clinical research
  • Rigorous manufacturing processes
  • Regulatory compliance
  • Continuous product innovation

To be the partner of choice for women and surgeons around the world, leading in science, reliability, and innovation in breast implant technology and medical aesthetic solutions.

We aim to continuously support the global surgical community by delivering:

  • Proven long-term safety data
  • Reliable silicone gel implant technology
  • Ongoing scientific collaboration
  • Responsible and transparent medical innovation

Through our Total Breast Care™ approach, we go beyond devices to support the full surgical journey, from consultation to long-term follow-up, helping surgeons improve patient compliance, optimize outcomes, and expand possibilities in both aesthetic and reconstructive procedures. By integrating solutions across pre-, intra-, and post-surgery, we enable more personalized treatments and support enhancement and hybrid procedures with greater confidence.

GC Aesthetics®新聞

GC Aesthetics® 團隊相遇

一個高增長、充滿活力的商業環境,讓才華橫溢的人有機會打造出優秀的職業生涯。

尋找 GC Aesthetics®

作為一家在超過70個國家擁有業務的全球公司,我們對未來感到興奮!尋找您當地的GCA®辦事處或經銷商。

加入 GC Aesthetics®

您有興趣貢獻於塑造醫療器械行業未來嗎?加入GCA®團隊。

免責聲明

*本線上IFU不能取代實際產品包裝內附的官方IFU。
本信息僅供醫護人員使用。在決定是否使用特定產品時,醫護人員必須始終依靠自己的專業臨牀判斷。GC Aesthetics®不提供醫療建議,建議醫護人員在使用任何特定產品進行程序或手術之前接受培訓。醫護人員在使用任何GC Aesthetics®產品之前,必須參考說明書,產品標籤和/或使用說明。提供的資訊旨在展示特定產品,以及完整的GC Aesthetics®產品目錄。產品可能未在所有市場上有供應。此網站上的所有內容和資訊僅供一般資訊目的。GC Aesthetics® 不對此處所含資訊的準確性作出任何陳述,亦不承擔任何責任,該資訊可能會在不通知的情況下發生變化。

1. Duteille F, et al. Eurosilicone圓形和解剖形矽膠乳房植入物的十年安全性資料. 美容整形外科學刊開放論壇. 2019;1(2):ojz012. 發表於2019年4月27日.